Academic Research: Where Do We Go From Here?

But even if conditions prove constraining in the short run, a long-run view of American science should provide some cause for hope. However, finding a path out of the predicament in which the basic research community currently finds itself will not be easy, nor will the results be inevitable. Rather, it is likely to depend on decisions being made right now by university leaders. It also may depend to a great extent on the influence

Written byRoger Geiger
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

But even if conditions prove constraining in the short run, a long-run view of American science should provide some cause for hope. However, finding a path out of the predicament in which the basic research community currently finds itself will not be easy, nor will the results be inevitable. Rather, it is likely to depend on decisions being made right now by university leaders. It also may depend to a great extent on the influence exerted by academic scientists involved in basic research.

Prompted in part by the current pessimism, I attempted to take a long-run view of the prospects for academic science in a paper for last winter's meeting of the American Association for the Advancement of Science. A simple question had for some time been in the back of my mind: In a society largely based on science and technology, will an increasing proportion of social resources be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies